ArticleCancer medicine2026

Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.

Jinguan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.